Biological Psychiatry

Plasma Protein Variations in Monozygotic Twins Discordant for Schizophrenia
pp. 437-442(6)
Authors: Vander Putten D.M.; Torrey E.F.; Larive A.B.; Merril C.R.

Relationships Between Verbal Memory Performance and the Cerebral Distribution of Fluorodeoxyglucose in Patients With Schizophrenia
pp. 443-451(9)
Authors: Mozley L.H.; Gur R.C.; Gur R.E.; Mozley P.D.; Alavi A.

Electroencephalography in Schizophrenic Patients: Comparison Between Neuroleptic-Naive State and After Treatment
pp. 452-456(5)
Authors: Nagase Y.; Okubo Y.; Toru M.

X Chromosome and Infantile Autism
pp. 457-464(8)
Authors: Petit E.; Herault J.; Raynaud M.; Cherpi C.; Perrot A.; Barthelemy C.; Lelord G.; Muh J.-P.

Initial Increase of Plasma Serotonin: A Biological Predictor for the Antidepressant Response to Clomipramine?
pp. 465-473(9)
Authors: Spreux-Varoquaux O.; Gailledreau J.; Vanier B.; Bothua D.; Plas J.; Chevalier J.-F.; Advenier C.; Pays M.; Brion S.

The Relationship Between Longitudinal Clinical Course and Sleep and Cortisol Changes in Adolescent Depression
pp. 474-484(11)
Authors: Rao U.; Dahl R.E.; Ryan N.D.; Birmaher B.; Williamson D.E.; Giles D.E.; Rao R.; Kaufman J.; Nelson B.

Sleep Electroencephalogram in Seasonal Affective Disorder and in Control Women: Effects of Midday Light Treatment and Sleep Deprivation
pp. 485-496(12)
Authors: Brunner D.P.; Krauchi K.; Dijk D.-J.; Leonhardt G.; Haug H.-J.; Wirz-Justice A.

Antipsychotic Drugs Block IP₃-Dependent Ca²⁺-Release From Rat Brain Microsomes
pp. 497-502(6)
Authors: Sczekan S.R.; Strumwasser F.

Induction of Tetradecanoyl Phorbol Acetate-Inducible Sequence (TIS) Genes by Electroconvulsive Shock in Rat Brain
pp. 503-507(5)
Authors: Hee Y.J.; Ung G.K.; Yong M.A.; Yeon H.J.; Park J.-B.; Yong S.K.

m-Chlorophenylpiperazine Challenge in Borderline Personality Disorder: Relationship of Neuroendocrine Response, Behavioral Response, and Clinical Measures
pp. 508-513(6)
Authors: Stein D.J.; Hollander E.; DeCaria C.M.; Simeon D.; Cohen L.; Aronowitz B.

Ondansetron Alters Human Alcohol Intoxication
pp. 514-521(8)
Authors: Swift R.M.; Davidson D.; Whelihan W.; Kuznetsov O.

Event-Related Brain Potentials in Children With Attention-Deficit and Hyperactivity Disorder: Effects of Stimulus Deviancy and Task Relevance in the Visual and Auditory Modality
pp. 522-534(13)
Authors: Kemner C.; Verbaten M.N.; Koelega H.S.; Buitelaar J.K.; van der Gaag R.J.; Camfferman G.; van Engeland H.

Cognitive Deficits in Patients With Chronic Fatigue Syndrome
pp. 535-541(7)
Authors: Marcel B.; Komaroff A.L.; Fagioli L.R.; Kornish R.J.; Albert M.S.

Serum Cholesterol and Treatment-Resistance in Schizophrenia
pp. 542-543(2)
Authors: Boston P.F.; Dursun S.M.; Zafar R.; Reveley M.A.

Headache Response to m-Chlorophenylpiperazine in Obsessive-Compulsive Disorder and Normal Controls
pp. 544-546(3)
Authors: Wong C.M.; Hollander E.

Intranasal Oxytocin in Obsessive-Compulsive Disorder
pp. 547-549(3)
Authors: Epperson C.N.; McDougle C.J.; Price L.H.

Effect of CI-988, a Cholecystokinin-B Receptor Antagonist, on Lactate-Induced Panic
pp. 550-552(3)
Authors: Cowley D.S.; Adams J.B.; Pyke R.E.; Cook J.; Zaccharias P.; Wingerson D.; Roy-Byrne P.P.

Urinary Epinephrine Excretion During Intelligence Testing in Attention-Deficit Hyperactivity Disorder and Normal Boys
pp. 553-555(3)
Authors: Hanna G.L.; Ornitz E.M.; Hariharan M.

Facial Expression in Schizophrenia
pp. 556-558(3)
Authors: Earnst K.S.; Kring A.M.; Kadar M.A.; Salem J.E.; Shepard D.A.; Loosen P.T.